Mosley Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-37
Closed -$1.44K – 815
2026
Q1
$1.44K Buy
+37
New +$1.88K ﹤0.01% 407

Other funds holding SBIO

Mosley Wealth Management's SBIO Position: Q2 2026 in Review

Mosley Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 37 shares — an estimated $1.44K sold.

Mosley Wealth Management first reported a position in SBIO in Q1 2026 and held it in 1 quarter. The position peaked at $1.44K in Q1 2026. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Mosley Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Mosley Wealth Management sold 37 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $1.44K.
  • Mosley Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q1 2026 and held it in 1 quarter.
  • Mosley Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $1.44K in Q1 2026.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.